Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H18O3 |
| Molecular Weight | 186.2481 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(O)=O)C1(O)CCCCC1
InChI
InChIKey=NIVFTEMPSCMWDE-UHFFFAOYSA-N
InChI=1S/C10H18O3/c1-2-8(9(11)12)10(13)6-4-3-5-7-10/h8,13H,2-7H2,1H3,(H,11,12)
| Molecular Formula | C10H18O3 |
| Molecular Weight | 186.2481 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Cyclobutyrol (CB) is a choleretic agent, which also inhibits biliary lipid secretion. Administration of cyclobutyrol reduced biliary concentration and output of cholesterol and phospholipid. This is due to an uncoupling of the secretion of cholesterol and phospholipids from that of bile acids. Biliary outputs of the canalicular membrane enzymes 5'-nucleotidase and alkaline phosphodiesterase I are depressed. The most likely effect of CB is exerted at the level of the canalicular membrane.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0033344 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2310370 |
|||
Target ID: GO:0033700 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2310370 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2574569
Single dose - 0.72 mmol/kg body weight
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:43:28 GMT 2025
by
admin
on
Wed Apr 02 07:43:28 GMT 2025
|
| Record UNII |
8T4L120N6M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
A05AX03
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
||
|
NCI_THESAURUS |
C66913
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
||
|
WHO-VATC |
QA05AX03
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
72065
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
100000083731
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
512-16-3
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
1149
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
SUB06851MIG
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
752
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
61024
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
DB13493
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
C81039
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
208-138-5
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
8T4L120N6M
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
CYCLOBUTYROL
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
21954
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | RxNorm | ||
|
m1096
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL1697739
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY | |||
|
DTXSID00862084
Created by
admin on Wed Apr 02 07:43:29 GMT 2025 , Edited by admin on Wed Apr 02 07:43:29 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |